Superior vena cava (SVC) syndrome comprises a constellation of clinical signs and
symptoms caused by obstruction of blood flow through the SVC. The management of …

Background The widespread use of central venous catheters, ports, pacemakers, and
defibrillators has increased the incidence of benign superior vena cava syndrome (SVCS) …

All CVWG members are listed in Table E1 (available online at www. jvir. org). No CVWG
members received compensation or commercial support for their time and effort. Some …

Purpose Endovascular stenting has been used to manage superior vena cava syndrome for
several decades and has become standard firstline practice. This study aims to investigate …

Superior vena cava stenting for the treatment of malignant superior vena cava obstruction is
now well established. It offers simple, rapid, and safe palliation of a distressing and …

Superior vena cava syndrome results from the obstruction of blood flow through the superior
vena cava and is most often due to thoracic malignancy. However, benign etiologies are on …

Background Superior vena cava (SVC) syndrome is caused by the obstruction of the SVC
and can result in significant morbidity and mortality. In contemporary practice, endovascular …

In the United States each year about 15,000 patients develop symptoms of venous
congestion of the head and neck due to occlusion of the superior vena cava (SVC) or …

Superior vena cava syndrome (SVCS) is a medical emergency that encompasses an array
of signs and symptoms due to obstruction of blood flow through the superior vena cava …

Rationale and Objectives To assess the efficacy and safety of percutaneous stenting for the
palliative treatment of malignant superior vena cava syndrome (SVCS). Methods and …